REVELATION BIOSCIENCES, INC. (REVB) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 32 transactions totaling $474.7K, demonstrating a bullish sentiment with $389.2K in net insider flow. The most recent transaction on Feb 4, 2026 involved a transaction of 13,100 shares valued at $21.6K.
No significant insider buying has been recorded for REVB in the recent period.
No significant insider selling has been recorded for REVB in the recent period.
Based on recent SEC filings, insider sentiment for REVB is bullish with an Insider Alignment Score of 91/100 and a net flow of $389.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at REVELATION BIOSCIENCES, INC. (REVB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading REVB stock, having executed 32 transactions in the past 90 days. The most active insider is James Rolke (Executive), who has made 3 transactions totaling $995.4K.
Get notified when executives and directors at REVB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Stanley Zygmont Chester III | Chief Financial Officer | Payment | 13,100 | $1.65 | $21.6K | C-Suite |
| Feb 3, 2026 | Rolke James | Executive | Payment | 8,521 | $1.86 | $15.8K | |
| Feb 3, 2026 | Carver Jennifer | Executive | Payment | 1,661 | $1.87 | $3.1K | |
| Feb 3, 2026 | S. Chawla Lakhmir | Executive | Payment | 2,261 | $1.85 | $4.2K | |
| Feb 3, 2026 | Roper Jess | Executive | Payment | 1,591 | $1.85 | $2.9K | |
| Jan 8, 2026 | Stanley Zygmont Chester III | Chief Financial Officer | Award | 78,145 | $0.90 | $70.3K | C-Suite |
| Jan 8, 2026 | Rolke James | Executive | Award | 532,829 | $0.90 | $479.5K | |
| Jan 8, 2026 | S. Chawla Lakhmir | Executive | Award | 41,981 | $0.90 | $37.8K | |
| Jan 8, 2026 | Roper Jess | Executive | Award | 41,981 | $0.90 | $37.8K | |
| Oct 29, 2025 | Roper Jess | Executive | Award | 15,625 | $1.28 | $20.0K | |
| Oct 29, 2025 | Stanley Zygmont Chester III | Executive | Award | 390,614 | $1.28 | $500.0K | |
| Oct 29, 2025 | Carver Jennifer | Executive | Award | 15,625 | $1.28 | $20.0K | |
| Oct 29, 2025 | Rolke James | Executive | Award | 390,614 | $1.28 | $500.0K | |
| Oct 29, 2025 | S. Chawla Lakhmir | Executive | Award | 15,625 | $1.28 | $20.0K | |
| Dec 8, 2023 | F. Tidmarsh George | Executive | Sale | 27,771 | $0.52 | $14.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 9 | $1.7M | 76.3% |
Purchase(P) | 10 | $431.9K | 19.6% |
Payment(F) | 5 | $47.7K | 2.2% |
Sale(S) | 7 | $42.8K | 1.9% |
Other(J) | 1 | $0 | 0.0% |
Insiders at REVELATION BIOSCIENCES, INC. are accumulating shares at an accelerated pace. With 7 insiders making 32 transactions totaling $431.9K in purchases versus $42.8K in sales, the net buying activity of $389.2K signals strong executive confidence. James Rolke (Executive) leads the buying activity with $995.4K in transactions across all time.